Drugsniper, a tool to exploit loss-of-function screens, identifies CREBBP as a predictive biomarker of VOLASERTIB in small cell lung carcinoma (SCLC)

  1. Carazo, F.
  2. Bértolo, C.
  3. Castilla, C.
  4. Cendoya, X.
  5. Campuzano, L.
  6. Serrano, D.
  7. Gimeno, M.
  8. Planes, F.J.
  9. Pio, R.
  10. Montuenga, L.M.
  11. Rubio, A.
Revue:
Cancers

ISSN: 2072-6694

Année de publication: 2020

Volumen: 12

Número: 7

Pages: 1-18

Type: Article

DOI: 10.3390/CANCERS12071824 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus